A systematic review of perceived risks, psychological and behavioral impacts of genetic testing

Genetics in Medicine

Volumn 10, Issue 1, 2008, Pages 19-32

  Heshka, Jodi T ^a   Palleschi, Crystal ^a   Howley, Heather ^a   Wilson, Brenda ^a   Wells, Philip S ^a,b,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Behavioral outcomes; Genetic testing; Perceived risk; Psychological outcomes; Systematic review

Indexed keywords

CA 125 ANTIGEN;

ALZHEIMER DISEASE; ANXIETY; BEHAVIOR; BREAST CANCER; BREAST EXAMINATION; BREAST SELF EXAMINATION; CANCER RISK; CANCER SCREENING; CLINICAL EVALUATION; COLORECTAL CARCINOMA; DEPRESSION; DIAGNOSTIC TEST; DISTRESS SYNDROME; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC RISK; GENETIC TESTING; HEALTH BEHAVIOR; HEALTH QUESTIONNAIRE 28; HEREDITARY NONPOLYPOSIS COLORECTAL CARCINOMA; HETEROZYGOTE; HOPKINS SYMPTOM CHECKLIST 25; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INFORMATION RETRIEVAL; MAMMOGRAPHY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; ONCOGENE; OUTCOME ASSESSMENT; OVARY CANCER; PATIENT EDUCATION; PROPHYLACTIC SURGERY; PROPHYLAXIS; PSYCHOLOGICAL ASPECT; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; STATE TRAIT ANXIETY INVENTORY; SYMPTOM CHECKLIST 90; SYSTEMATIC REVIEW; TRANSVAGINAL ECHOGRAPHY;

GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; RISK ASSESSMENT;

EID: 38149036642     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e31815f524f     Document Type: Review

References (48)

1. Terdiman JP, Conrad PG, Sleisenger MH. Genetic testing in hereditary colorectal cancer: indications and procedures. Am J Gastroenterol 1999;94:2344-2356.
2. Peltomaki P, Aaltonen LA, Sistonen P, Pylkannen L, et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science 1993;260:810-812.
3. Lindblom A, Tannergard P, Werelius B, Nordenskjold M. Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nat Genet 1993;5:279-282.
4. Nystrom-Lahti M, Parsons R, Sistonen P, Pylkkanen L, et al. Mismatch repair genes on chromosomes 2p and 3p account for a major share of hereditary nonpolyposis colorectal cancer families evaluable by linkage. Am J Hum Gen 1994;55:659- 665.
5. Nicolaides NC, Papadopoulos N, Liu B, Wei YF, et al. Mutations of two PMS homologues in hereditary non-polyposis colon cancer. Nature 1994;371:75-80.
6. Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH, et al. Cancer risk in families with hereditary non-polyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110:1020-1027.
7. Aarnio M, Sankila R, Pukkala E, Salovaara R, et al. Cancer risk in mutation carriers of DNA mismatch repair genes. Int J Cancer 1999;81:214-218.
8. National Cancer Institute. Available at: http://www.cancer.gov/.
9. Cupples LA, Farrer LA, Sadovnik AD, Relkin N, et al. Estimating risk curves for first-degree relatives of patients with Alzheimer disease: the REVEAL study. Genet Med 2004;6:192-196.
10. Moher D, Cook DJ, Eastwood S, Olkin I, et al. Improving the quality of reports of meta-analysis of randomized controlled trials: the QUORUM statement. Lancet 1999;354:1896-1900.
11. Kinney AY, Bloor LE, Mandal D, Simonsen SE, et al. The impact of receiving genetic test results on general and cancer-specific psychologic distress among members of an African-American kindred with BRCA1 mutation. Cancer 2005;104:2508-2516.
12. Kinney AY, Simonsen SE, Baty BJ, Mandal D, et al. Risk reduction behaviors and provider communication following genetic counseling and BRCA1 mutation testing in an African American kindred. J Genet Couns 2006;15:293-305.
13. Watson M, Foster C, Eeles R, Eccles D, et al. Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort. Br J Cancer 2004;91:1787-1794.
14. Liede A, Metcalfe K, Hanna D, Hoodfar E, et al. Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling. Am J Hum Genet 2000;67:1494-1504.
15. Andrews L, Meiser B, Apicella C, Tucker K. Psychological impact of genetic testing for breast cancer susceptibility in women of Ashkenazi Jewish background: a prospective study. Genet Test 2004;8:240-247.
16. Botkin JR, Smith KR, Croyle RT, Baty BJ, et al. Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing. Am J Med Genet 2003;118:201-209.
17. Claes E, Evers-Kiebooms G, Denayer L, Decruyenaere M, et al. Predictive genetic testing for hereditary breast and ovarian cancer: psychological distress and illness representations 1 year following disclosure. J Genet Couns 2005;14:349-363.
18. Lerman C, Hughes C, Croyle RT, Main D, et al. Prophylactic surgery decisions and surveillance practices one year following BRCA 1/2 testing. Prev Med 2000;31:75-80.
19. Lodder L, Frets PG, Trijsburg RW, Tibben A, et al. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing. Eur J Hum Genet 2001;9:492-500.
20. Lodder L, Frets PG, Trijsburg RW, Meijers-Heijboer, et al. Psychological impact of receiving a BRCA1/BRCA2 test result. Am J Med Genet 2001;98:15-24.
21. van Oostrom I, Meijers-Heijboer H, Lodder LN, Duivenvoorden HJ, et al. Longterm psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. J Clin Oncol 2003;21:3867-3874.
22. Lodder LN, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, et al. One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery). Breast Cancer Res Treat 2002;73:97-112.
23. Lynch HT, Snyder C, Lynch JF, Karatoprakli P, et al. Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families. Cancer Genet Cytogenet 2006;165:91-97.
24. Meijers-Heijboer E, Verhoog L, Brekelmans C, Seynaeve C, et al. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet 2000;355:2015-2020.
25. Meiser B, Butow P, Friedlander M, Barratt A, et al. Psychological impact of genetic testing in women from high-risk breast cancer families. Eur J Cancer 2002;38:2025-2031.
26. Metcalfe KA, Snyder C, Seidel J, Hanna D, et al. The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation. Fam Cancer 2005;4:97-103.
27. Peshkin BN, Schwartz MD, Isaacs C, Hughes C, et al. Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing. Cancer Epidemiol Biomarkers Prev 2002;11:1115-1118.
28. Reichelt JG, Heimdal K, Moller P, Dahl AA. BRCA1 testing with definitive results: a prospective study of psychological distress in a large clinic-based sample. Fam Cancer 2004;3:21-28.
29. Schwartz MD, Peshkin BN, Hughes C, Main D, et al. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. J Clin Oncol 2002;20:514-520.
30. van Roosmalen MS, Stalmeier PF, Verhoef LC, Hoekstra-Weebers JE, et al. Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer. Am J Med Genet 2004;124:346-355.
31. Aktan-Collan K, Haukkala A, Mecklin JP, Uutela A, et al. Comprehension of cancer risk one and 12 months after predictive genetic testing for hereditary non-polyposis colorectal cancer. J Med Genet 2001;38:787-792.
32. Claes E, Denayer L, Evers-Kiebooms G, Boogaerts A, et al. Predictive testing for hereditary nonpolyposis colorectal cancer: subjective perception regarding colorectal and endometrial cancer, distress, and health-related behavior at one year posttest. Genet Test 2005;9:54-65.
33. Claes E, Denayer L, Evers-Kiebooms G, Boogaerts A, et al. Predictive testing for hereditary non-polyposis colorectal cancer: motivation, illness representations and short-term psychological impact. Patient Educ Couns 2004;55:265-274.
34. Collins V, Meiser B, Gaff C, St John DJ, et al. Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma. Cancer 2005;104:273-281.
35. Gritz ER, Peterson SK, Vernon SW, Marani SK, et al. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 2005;23:1902-1910.
36. Hadley DW, Jenkins JF, Dimond E, de Carvalho M, et al. Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 2004;22:39-44.
37. Halbert CH, Lynch H, Lynch J, Main D, et al. Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations. Arch Intern Med 2004;164:1881-1887.
38. Johnson KA, Trimbath JD, Petersen GM, Griffin CA, et al. Impact of genetic counseling and testing on colorectal cancer screening behaviour. Genet Test 2002;6:303-306.
39. Meiser B, Collins V, Warren R, Gaff C, et al. Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer. Clin Genet 2004;66:502-511.
40. Murakami Y, Okamura H, Sugano K, Yoshida T, et al. Psychologic distress after disclosure of genetic test results regarding hereditary nonpolyposis colorectal carcinoma. Cancer 2004;101:395-403.
41. Ponz de Leon M, Benatti P, Di Gregorio C, Pedroni M, et al. Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer. Br J Cancer 2004;90:882-887.
42. Arver B, Haegermark A, Platten U, Lindblom A, et al. Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-up. Fam Cancer 2004;3:109-116.
43. Roberts JS, Cupples LA, Relkin NR, Whitehouse PJ, et al. Genetic risk assessment for adult children of people with Alzeimer's Disease: the risk evaluation and education for Alzeimer's Disease (REVEAL) Study. J Geriatr Psychiatry Neurol 2005;18:250-255.
44. Romero LJ, Garry PJ, Schuyler M, Bennahum DA, et al. Emotional responses to APO E genotype disclosure for Alzheimer disease. J Genet Couns 2005;14:141-150.
45. Meiser B. Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psychooncology 2005;14:1060-1074.
46. Schlich-Bakker KJ, ten Kroode HFJ, Ausems MG. A literature review of the psychological impact of genetic testing on breast cancer patients. Patient Educ Couns 2006;62:13-20.
47. Nelson HD, Huffman LH, Fu R, Harris EL. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. preventive services task force. Ann Intern Med 2005;143:362-379.
48. Wainberg S, Husted J. Utilization of screening and preventive surgery among unaffected carriers of BRCA1 or BRCA2 gene mutation. Cancer Epidemiol Biomarkers Prev 2004;13:1989-1995.